PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

BACKGROUND: A sequential combination of radiochemotherapy/endocrinotherapy and cytokine-induced killer cell (CIK) infusion has been shown to be an effective therapy for post-mastectomy breast cancer based on statistical analysis of the patient population. However, whether an individual could obtain...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Immunother Cancer
Main Authors: Zhou, Zi-Qi, Zhao, Jing-Jing, Pan, Qiu-Zhong, Chen, Chang-Long, Liu, Yuan, Tang, Yan, Zhu, Qian, Weng, De-Sheng, Xia, Jian-Chuan
格式: Artigo
語言:Inglês
出版: BioMed Central 2019
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6712838/
https://ncbi.nlm.nih.gov/pubmed/31455411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0696-8
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍